What is the recommended treatment for gonorrhea, considering potential co-infection with chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gonorrhea Treatment

Treat uncomplicated gonorrhea with ceftriaxone 500 mg intramuscularly as a single dose, and add doxycycline 100 mg orally twice daily for 7 days if chlamydia co-infection has not been excluded. 1, 2, 3

Primary Treatment Regimen

  • Ceftriaxone 500 mg IM (single dose) is the foundation of gonorrhea treatment, achieving 99.1% cure rates for urogenital, anorectal, and pharyngeal infections 1, 4, 3
  • Add doxycycline 100 mg orally twice daily for 7 days to cover chlamydia unless co-infection has been definitively ruled out 1, 2, 3
  • Co-infection rates are extremely high (40-50% of gonorrhea patients also have chlamydia), making presumptive dual therapy essential 1, 2

Alternative Single-Dose Regimen (When Compliance is Uncertain)

  • If you cannot ensure patient adherence to 7-day doxycycline, use ceftriaxone 500 mg IM PLUS azithromycin 1 g orally (both single doses) 1, 4
  • This regimen provides single-dose coverage for both infections but raises antimicrobial stewardship concerns due to azithromycin resistance patterns 3
  • Never use azithromycin 1 g alone for gonorrhea—it has only 93% efficacy 1, 4, 5

When Ceftriaxone is Unavailable

  • Use cefixime 400 mg orally (single dose) PLUS azithromycin 1 g orally (single dose) 1, 4
  • Mandatory test-of-cure at 1 week is required with this regimen due to inferior efficacy compared to ceftriaxone 1, 4
  • Cefixime has declining effectiveness with rising minimum inhibitory concentrations 4

Severe Cephalosporin Allergy

  • First-line alternative: Gentamicin 240 mg IM PLUS azithromycin 2 g orally (single dose), which achieved 100% cure rate in clinical trials 4, 6
  • Second-line alternative: Azithromycin 2 g orally alone (single dose), but this has lower efficacy (93%) and causes gastrointestinal side effects in 35% of patients 1, 4, 5
  • Spectinomycin 2 g IM has only 52% efficacy for pharyngeal infections—avoid if pharyngeal exposure is suspected 1, 2, 4

Critical Site-Specific Considerations

  • Pharyngeal gonorrhea is significantly more difficult to eradicate than urogenital or anorectal infections 1, 2, 4
  • Ceftriaxone 500 mg IM is the only reliably effective treatment for pharyngeal infections, with superior efficacy compared to all oral alternatives 1, 4
  • Most ceftriaxone treatment failures involve the pharynx, not urogenital sites 4

What NOT to Use

  • Never use fluoroquinolones (ciprofloxacin, ofloxacin) due to widespread resistance, despite their historical 99.8% cure rates in 1998 7, 1, 2, 4
  • Never use azithromycin 1 g alone—insufficient efficacy at only 93% 1, 4, 5
  • Avoid spectinomycin for pharyngeal infections (only 52% effective) 1, 2, 4

Special Populations

Pregnancy

  • Use ceftriaxone 500 mg IM PLUS azithromycin 1 g orally (single dose) 1, 2, 4
  • Never use doxycycline, quinolones, or tetracyclines in pregnancy 2, 4, 8
  • If azithromycin cannot be used, amoxicillin 500 mg three times daily for 7 days covers chlamydia 2

Men Who Have Sex with Men (MSM)

  • Use only ceftriaxone-based regimens due to higher prevalence of resistant strains 4
  • Never use quinolones in this population 4
  • Do not use expedited partner therapy due to high risk of undiagnosed coexisting STDs or HIV 4

Follow-Up Requirements

  • Patients treated with recommended ceftriaxone-based regimens do NOT need routine test-of-cure unless symptoms persist 1, 2, 4, 9
  • Mandatory test-of-cure at 1 week is required for patients receiving cefixime or azithromycin monotherapy 1, 4
  • All patients should be retested approximately 3 months after treatment due to high reinfection risk (most positive tests represent reinfection, not treatment failure) 1, 2, 9
  • Pregnant women with antenatal gonococcal infection should be retested in the third trimester unless recently treated 9

When Symptoms Persist After Treatment

  • Obtain culture with antimicrobial susceptibility testing immediately 2, 4
  • Report suspected treatment failure to local public health officials within 24 hours 4
  • Consult an infectious disease specialist 4
  • Recommended salvage regimens include gentamicin 240 mg IM PLUS azithromycin 2 g orally, or ertapenem 1 g IM for 3 days 4

Partner Management

  • All sexual partners from the preceding 60 days must be evaluated and treated with the same dual therapy regimen 7, 1, 2, 4
  • If partners cannot be linked to timely evaluation, consider expedited partner therapy with oral combination therapy (cefixime 400 mg plus azithromycin 1 g), except in MSM 4
  • Patients should avoid sexual intercourse until therapy is completed and both patient and partners are asymptomatic 7, 1, 2

Additional Testing at Diagnosis

  • Screen for syphilis with serology at the time of gonorrhea diagnosis 4
  • Perform HIV testing given that gonorrhea facilitates HIV transmission 4, 3

References

Guideline

Single-Dose Empiric Therapy for Gonorrhea and Chlamydia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prophylactic Treatment for Chlamydia and Gonorrhea After STD Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.

MMWR. Morbidity and mortality weekly report, 2020

Guideline

Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.